Pacific Biosciences Of California, Inc. has a market cap of $80.9 million; its shares were traded at around $1.51 with and P/S ratio of 2.4.
This is the annual revenues and earnings per share of PACB over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PACB.
CEO Recent Trades:
- Chairman, CEO & President Michael Hunkapiller bought 186,400 shares of PACB stock on 11/26/2012 at the average price of 1.44. Michael Hunkapiller owns at least 1,103,700 shares after this. The price of the stock has increased by 4.86% since.
- Chairman, CEO & President Michael Hunkapiller bought 155,000 shares of PACB stock on 11/20/2012 at the average price of 1.27. Michael Hunkapiller owns at least 917,300 shares after this. The price of the stock has increased by 18.9% since.
- Chairman, CEO & President Michael Hunkapiller bought 262,300 shares of PACB stock on 11/16/2012 at the average price of 1.16. Michael Hunkapiller owns at least 762,300 shares after this. The price of the stock has increased by 30.17% since.
- Chairman, CEO & President Michael Hunkapiller bought 400,000 shares of PACB stock on 08/07/2012 at the average price of 1.75. Michael Hunkapiller owns at least 500,000 shares after this. The price of the stock has decreased by 13.71% since.
For the complete insider trading history of PACB, click here.







RSS